Related Experiment Video
Updated: Feb 28, 2026

Characterizing DNA Repair Processes at Transient and Long-lasting Double-strand DNA Breaks by Immunofluorescence Microscopy
Published on: June 8, 2018
Cellular strategies for repairing trapped protein-DNA complexes
Maria Sideridou1,2, Doukissa Ioanna Machli1, Dora Lontra1
1Biomedical Research Foundation, Academy of Athens, Athens, Greece.
Abstract:
DNA-protein crosslinks (DPCs) are highly toxic DNA lesions that arise both from normal cellular metabolism and as an intended consequence of cancer chemotherapy. Key anticancer agents, including topoisomerase poisons and PARP inhibitors, exert their therapeutic effects by trapping enzymes on DNA, converting them into toxic barriers that block replication. To counteract this threat, cells have evolved specialized mechanisms to detect and remove DPCs. This review explores the molecular mechanisms by which these therapies trap proteins on DNA and the multi-layered defense systems cells use to resolve them-ranging from enzymatic degradation to mechanical extraction. We further examine how these processes are modulated by the cell cycle and chromatin landscape. Importantly, we highlight emerging evidence that alterations in DPC repair pathways are frequent in cancer and serve as critical determinants of treatment response. Ultimately, this review integrates mechanistic insights with clinical data to highlight how exploiting DPC repair defects can overcome drug resistance and guide the development of rational, synthetic lethal combination therapies.
Insights
DNA-protein crosslinks (DPCs) are toxic lesions repaired by specialized cellular mechanisms. Understanding DPC repair is crucial for developing effective cancer therapies and overcoming drug resistance.
Area of Science:
- Molecular Biology
- Cancer Biology
- Biochemistry
Background:
- DNA-protein crosslinks (DPCs) are toxic DNA lesions formed during normal metabolism and cancer chemotherapy.
- Anticancer drugs like topoisomerase poisons and PARP inhibitors induce DPCs by trapping enzymes on DNA, creating replication barriers.
Purpose of the Study:
- To review the molecular mechanisms of DPC formation by anticancer therapies.
- To explore cellular defense systems for DPC detection and resolution.
- To examine the role of DPC repair in cancer and its implications for treatment.
Main Methods:
- Literature review of molecular mechanisms.
- Analysis of cellular DPC repair pathways.
- Integration of mechanistic insights with clinical data on cancer treatment.
Main Results:
- Cells employ multi-layered defense systems, including enzymatic degradation and mechanical extraction, to resolve DPCs.
- DPC repair processes are modulated by the cell cycle and chromatin structure.
- Alterations in DPC repair pathways are common in cancer and influence treatment response.
Conclusions:
- Exploiting DPC repair defects offers a strategy to overcome drug resistance in cancer.
- Understanding DPC repair is key to developing rational, synthetic lethal combination therapies.
More Related Videos
13:10Detection and Visualization of DNA Damage-induced Protein Complexes in Suspension Cell Cultures Using the Proximity Ligation Assay
Published on: June 9, 2017
11:58A Simple, Rapid, and Quantitative Assay to Measure Repair of DNA-protein Crosslinks on Plasmids Transfected into Mammalian Cells
Published on: March 5, 2018
Related Concept Videos
Homologous Recombination
Fixing Double-strand Breaks
Fixing Double-strand Breaks
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Overview of DNA Repair
Chemically...